DK1750744T3 - Lægemiddel til behandling af svampeinfektioner, især aspergillose - Google Patents

Lægemiddel til behandling af svampeinfektioner, især aspergillose

Info

Publication number
DK1750744T3
DK1750744T3 DK05742910T DK05742910T DK1750744T3 DK 1750744 T3 DK1750744 T3 DK 1750744T3 DK 05742910 T DK05742910 T DK 05742910T DK 05742910 T DK05742910 T DK 05742910T DK 1750744 T3 DK1750744 T3 DK 1750744T3
Authority
DK
Denmark
Prior art keywords
aspergillosis
drug
treatment
fungal infections
fungal
Prior art date
Application number
DK05742910T
Other languages
Danish (da)
English (en)
Inventor
Luigina Romani
Giovanni Salvatori
Paolo Carminati
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1750744T3 publication Critical patent/DK1750744T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK05742910T 2004-05-07 2005-04-28 Lægemiddel til behandling af svampeinfektioner, især aspergillose DK1750744T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000223A ITRM20040223A1 (it) 2004-05-07 2004-05-07 Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
PCT/IT2005/000247 WO2005107791A1 (en) 2004-05-07 2005-04-28 Medicament for the treatment of fungal infections, particularly aspergillosis

Publications (1)

Publication Number Publication Date
DK1750744T3 true DK1750744T3 (da) 2008-09-29

Family

ID=34968212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05742910T DK1750744T3 (da) 2004-05-07 2005-04-28 Lægemiddel til behandling af svampeinfektioner, især aspergillose

Country Status (25)

Country Link
US (2) US8778389B2 (zh)
EP (1) EP1750744B1 (zh)
JP (1) JP5574565B2 (zh)
KR (1) KR101192611B1 (zh)
CN (1) CN1950104B (zh)
AR (1) AR048775A1 (zh)
AT (1) ATE397937T1 (zh)
AU (1) AU2005239913B2 (zh)
BR (1) BRPI0510718A (zh)
CA (1) CA2563400C (zh)
CY (1) CY1108332T1 (zh)
DE (1) DE602005007485D1 (zh)
DK (1) DK1750744T3 (zh)
ES (1) ES2306145T3 (zh)
HK (1) HK1103961A1 (zh)
HR (1) HRP20080413T3 (zh)
IT (1) ITRM20040223A1 (zh)
ME (1) ME02743B (zh)
MX (1) MXPA06012889A (zh)
PL (1) PL1750744T3 (zh)
PT (1) PT1750744E (zh)
RS (1) RS50591B (zh)
SI (1) SI1750744T1 (zh)
TW (1) TWI393569B (zh)
WO (1) WO2005107791A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
ITMI20062448A1 (it) * 2006-12-19 2008-06-20 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio dell¿ aspergillosi invasiva
US8838152B2 (en) 2007-11-30 2014-09-16 Microsoft Corporation Modifying mobile device operation using proximity relationships
CN101280326B (zh) * 2008-05-14 2011-07-06 中国科学院微生物研究所 一种抑制烟曲霉活性的化合物制备方法及其应用
EP2865384B1 (en) * 2012-06-22 2018-08-15 The University of Tokyo Agent for treating or preventing systemic inflammatory response syndrome
WO2019229241A1 (en) * 2018-06-01 2019-12-05 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of invasive fungal infections
EP3669885A1 (en) * 2018-12-20 2020-06-24 Humanitas Mirasole S.p.A. Use of sap for the treatment of eurotiomycetes fungi infections
CN113952401B (zh) * 2021-12-15 2022-10-25 河北农业大学 一种用于防治畜禽曲霉菌感染的中药及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
JP2001183375A (ja) 1999-12-27 2001-07-06 Tosoh Corp 酵素標識抗体
US20050187161A1 (en) * 2003-09-12 2005-08-25 Board Of Regents, The University Of Texas System Biopanning as an approach to study the pathogenesis of and produce novel treatment modalities for invasive Aspergillosis
US7109380B2 (en) * 2004-03-29 2006-09-19 The University Of Mississippi Cyclopentenedione antifungal compounds and methods for their use
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
US8337828B2 (en) * 2006-05-02 2012-12-25 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection

Also Published As

Publication number Publication date
PT1750744E (pt) 2008-08-14
JP2007536380A (ja) 2007-12-13
MXPA06012889A (es) 2007-02-15
BRPI0510718A (pt) 2007-11-20
ME02743B (me) 2010-05-07
RS50591B (sr) 2010-05-07
ES2306145T3 (es) 2008-11-01
AU2005239913A1 (en) 2005-11-17
US20140296135A1 (en) 2014-10-02
US8778389B2 (en) 2014-07-15
CY1108332T1 (el) 2014-02-12
ITRM20040223A1 (it) 2004-08-07
US20080026997A1 (en) 2008-01-31
SI1750744T1 (sl) 2008-10-31
ATE397937T1 (de) 2008-07-15
EP1750744B1 (en) 2008-06-11
WO2005107791A1 (en) 2005-11-17
EP1750744A1 (en) 2007-02-14
HRP20080413T3 (en) 2008-10-31
KR101192611B1 (ko) 2012-10-18
KR20070007375A (ko) 2007-01-15
TW200602075A (en) 2006-01-16
AU2005239913B2 (en) 2011-08-18
JP5574565B2 (ja) 2014-08-20
CA2563400C (en) 2013-07-30
TWI393569B (zh) 2013-04-21
HK1103961A1 (en) 2008-01-04
CN1950104B (zh) 2010-11-10
DE602005007485D1 (de) 2008-07-24
CA2563400A1 (en) 2005-11-17
PL1750744T3 (pl) 2008-11-28
CN1950104A (zh) 2007-04-18
AR048775A1 (es) 2006-05-24

Similar Documents

Publication Publication Date Title
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK1750744T3 (da) Lægemiddel til behandling af svampeinfektioner, især aspergillose
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
NL1029015A1 (nl) Therapeutische verbindingen.
DE602006011930D1 (de) Kämpfung von infektionen
DK1765288T3 (da) Tobramycinpræparater til behandling af endobronchiale infektioner
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
NL1028193A1 (nl) Farmaceutisch werkzame verbindingen.
NO20064555L (no) HIV-integraseinhibitorer.
DK1907037T3 (da) Medikamentdispenser.
DK1868600T3 (da) Spirocyklisk cyclohexanderivat til behandling af stofafhængighed
DK1732604T3 (da) Fremgangsmåder til behandling af hiv-infektion
CL2007001630A1 (es) Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
DK1942967T3 (da) Fremgangsmåde til dosering af medikamenter
DK1879580T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
DK1879581T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater som lægemidler til behandling af infertilitet
DK1814572T3 (da) Depsipeptider til forebyggelse af vertikale endoparasitinfektioner
IS8559A (is) Lyfjasamsetning gegn sveppagerlum
BRPI0614413A2 (pt) composto, e, composição farmacêutica
BRPI0614412A2 (pt) composto, e, composição farmacêutica
ES1057367Y (es) Recubrimiento de piscinas.